Down Syndrome Research

Diadem US, Inc., based in Palo Alto, California, is a dedicated diagnostic company focused on advancing early detection and monitoring of Alzheimer's disease. Their innovative blood-based test, AlzoSure, utilizes a proprietary antibody to identify specific biomarkers associated with the onset of Alzheimer's, aiming to provide a fast, non-invasive, and cost-effective diagnostic solution. Committed to addressing significant challenges in Alzheimer's drug development and patient care, Diadem collaborates with leading experts from both industry and academia. The company is preparing for extensive clinical trials to validate their initial findings and enhance patient recruitment for clinical studies related to Alzheimer's treatments. Generated from the website